Your browser doesn't support javascript.
loading
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Tamari, Roni; McLornan, Donal P; Ahn, Kwang Woo; Estrada-Merly, Noel; Hernández-Boluda, Juan Carlos; Giralt, Sergio; Palmer, Jeanne; Gale, Robert Peter; DeFilipp, Zachariah; Marks, David I; van der Poel, Marjolein; Verdonck, Leo F; Battiwalla, Minoo; Diaz, Miguel Angel; Gupta, Vikas; Ali, Haris; Litzow, Mark Robert; Lazarus, Hillard M; Gergis, Usama; Bashey, Asad; Liesveld, Jane; Hashmi, Shahrukh; Pu, Jeffrey J; Beitinjaneh, Amer; Bredeson, Christopher; Rizzieri, David; Savani, Bipin N; Abid, Muhammad Bilal; Ganguly, Siddhartha; Agrawal, Vaibhav; Ulrike Bacher, Vera; Wirk, Baldeep; Jain, Tania; Cutler, Corey; Aljurf, Mahmoud; Kindwall-Keller, Tamila; Kharfan-Dabaja, Mohamed A; Hildebrandt, Gerhard C; Pawarode, Attaphol; Solh, Melhem M; Yared, Jean A; Grunwald, Michael R; Nathan, Sunita; Nishihori, Taiga; Seo, Sachiko; Scott, Bart L; Nakamura, Ryotaro; Oran, Betul; Czerw, Tomasz; Yakoub-Agha, Ibrahim.
Affiliation
  • Tamari R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • McLornan DP; Department of Medicine, University College Hospital, London, United Kingdom.
  • Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
  • Estrada-Merly N; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
  • Hernández-Boluda JC; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
  • Giralt S; Department of Hematology, Hospital Clínico Universitario, Valencia, Spain.
  • Palmer J; Department of Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Gale RP; Department of Medicine, Mayo Clinic Arizona and Phoenix Children's Hospital, Phoenix, AZ.
  • DeFilipp Z; Department of Immunology and Inflammation, Haematology Centre, Imperial College London, London, United Kingdom.
  • Marks DI; Department of Medicine, Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.
  • van der Poel M; Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
  • Verdonck LF; Division of Hematology, Department of Internal Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Battiwalla M; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
  • Diaz MA; Outcomes Research, Sarah Cannon Blood Cancer Network, Nashville, TN.
  • Gupta V; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
  • Ali H; Department of Internal Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Litzow MR; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Lazarus HM; Division of Hematology and Transplant Center, Mayo Clinic, Rochester, MN.
  • Gergis U; Department of Hematology and Internal Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH.
  • Bashey A; Division of Hematological Malignancies, Department of Medicine Oncology, Thomas Jefferson University, Philadelphia, PA.
  • Liesveld J; Department of Medicine, Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA.
  • Hashmi S; Department of Medicine, University of Rochester Medical Center, Rochester, NY.
  • Pu JJ; Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Beitinjaneh A; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
  • Bredeson C; Department of Medicine, Banner University Medical Center Tucson, Syracuse, NY.
  • Rizzieri D; Divison of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL.
  • Savani BN; Department of Medicine, The Ottawa Hospital Transplant & Cellular Therapy Program, Ottawa, ON, Canada.
  • Abid MB; Novant Health Cancer Institute, Winston Salem, NC.
  • Ganguly S; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Agrawal V; Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • Ulrike Bacher V; Department of Medicine, Houston Methodist Hospital and Cancer Center, Houston, TX.
  • Wirk B; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Jain T; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Cutler C; Department of Medicine, Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA.
  • Aljurf M; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Kindwall-Keller T; Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA.
  • Kharfan-Dabaja MA; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Hildebrandt GC; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA.
  • Pawarode A; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.
  • Solh MM; Division of Hematology, Markey Cancer Center, University of Kentucky, Lexington, KY.
  • Yared JA; Division of Hematology/Oncology, Department of Internal Medicine, Blood and Marrow Transplantation Program, University of Michigan Medical School, Ann Arbor, MI.
  • Grunwald MR; The Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA.
  • Nathan S; Division of Hematology/Oncology, Department of Medicine, Transplantation & Cellular Therapy Program, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD.
  • Nishihori T; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Seo S; Department of Internal Medicine, Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL.
  • Scott BL; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Nakamura R; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Oran B; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Czerw T; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Yakoub-Agha I; Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood Adv ; 7(15): 3993-4002, 2023 08 08.
Article in En | MEDLINE | ID: mdl-37134306
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Primary Myelofibrosis Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Primary Myelofibrosis Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: United States